Eyes On Tomorrow

Peter Scanlon: future talk

Listen on

Episode notes

Professor Peter Scanlon shares his experiences of AI in diabetic retinopathy screening, how it could be introduced and its potential benefits and pitfalls.

He also talks about the impact of obesity on the prevalence of diabetes globally and how this varies between different racial groups. Finally, he touches on how improved glycemic control with modern insulin delivery systems has reduced the incidence of sight threatening retinopathy.

Get full access to Eyes On Tomorrow at eyesontomorrow.substack.com/subscribe